Dr. Francisco G. Pernas, MD

Dr. Pernas practices at South Florida ENT Associates, Inc. in Miami Lakes, Florida.

Dr. Pernas' NPI, 1932309754, was assigned on July 19, 2007. Dr. Pernas graduated from University of Miami, Miller School of Medicine in 2006. Dr. Pernas holds Florida license ME 108710.

Dr. Pernas' primary practice is South Florida ENT Associates, Inc., at 15280 Nw 79th Ct, Miami Lakes, FL 33016 in Miami-Dade County. The practice phone is (305) 558-3724.

Dr. Pernas' primary practice is South Florida ENT Associates, Inc. in Miami Lakes, Florida. Dr. Pernas is also affiliated with Baptist Health Baptist Hospital. The medical group on file is South Florida ENT Associates. Dmand AI also links Dr. Pernas to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Pernas practices, 3 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Pernas' primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Pernas is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Pernas' licenses on file in 2 states: Florida and Texas.

Dmand AI lists acute sinusitis, chronic ear infection, chronic nasal allergies, chronic sinusitis, ear eustachian tube disorders, ear infection, endoscopic sinus surgery and hearing loss and impairment among the conditions Dr. Pernas treats.

CMS data shows 1,081 Medicare services from Dr. Pernas across 17 procedure codes in 2024, for 287 Medicare patients. Medicare paid $82,740 for them. Every service was in an office.

CMS counts 287 Medicare patients who saw Dr. Pernas in 2024. The largest group is 65 to 74, with 129 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 19% are also on Medicaid. Their average risk score is 1.38, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Pernas' median patient age at 59, with 55% women.

In 2024, Dr. Pernas wrote 1,992 Medicare Part D claims for 642 patients. 95% of them were for generic drugs. CMS names the drug for 1,868 of them, across 22 drugs with 11 or more claims each, at $137,834 in total drug cost. In 2023, CMS named 2,393 claims across 23 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Pernas for performance year 2024, reported individually. Dr. Pernas accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 7 papers to Dr. Pernas, published from 2006 to 2012. The most frequent topics are Carcinoma, Squamous Cell, Head and Neck Neoplasms and Antineoplastic Agents. Dr. Pernas has published most often in Clin Cancer Res. Dr. Pernas' most frequent co-authors are Patricia Anne Maeso, MD, Andrew M. Coughlin, MD and Praveen Duggal, MD.

CMS Open Payments shows 433 general payments to Dr. Pernas from 35 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 71% of the total. Optinose US, Inc. paid the most, $67,159.

Dmand AI lists 1 award for Dr. Pernas, most recently CMS Stage 1 EHR in 2013.

Dr. Pernas graduated from University of Miami, Miller School of Medicine in 2006.

Dr. Pernas is in network with 17 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.